梓橦宫：关于部分募投项目结项并将节余募集资金永久补充流动资金的公告
Sichuan Zitonggong Pharmaceuticals Sichuan Zitonggong Pharmaceuticals (BJ:832566) Zheng Quan Ri Bao·2026-01-15 13:19

Core Viewpoint - The company announced the completion of certain fundraising projects and plans to use the remaining funds to permanently supplement its working capital [2] Group 1 - The company held its 17th meeting of the fourth board of directors on January 15, 2026 [2] - The projects "Production Intelligent Upgrade Construction Project" and "Marketing Network Construction Project" have been completed and are in a state of readiness for use [2] - To improve the efficiency of fundraising, the company intends to conclude the aforementioned projects and allocate the surplus funds for permanent working capital [2]